Skip to main content
DNA Labs India

TRIM37 Gene Mulibrey nanism NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

TRIM37 Gene Mulibrey nanism NGS Genetic Test

Short Name: TRIM37 NGS

Also known as: Mulibrey Nanism Genetic Test, TRIM37 Gene Sequencing

TRIM37 Gene Mulibrey nanism NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.

NGSPediatric🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify disease-causing mutations in the TRIM37 gene to confirm a diagnosis of Mulibrey nanism in individuals presenting with characteristic clinical features. It also aids in carrier detection for at-risk family members and provides essential information for genetic counseling and reproductive planning.

Test Code
5856
CPT Code
81406
ICD Code
Q87.1
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation required. However, a genetic counseling session is recommended prior to testing to discuss the implications and obtain informed consent.

Method: Venipuncture or Fingerstick

Step 2

Laboratory Analysis

Blood sample is collected by a trained phlebotomist using sterile techniques. For FTA card, a drop of blood is placed on the card and allowed to dry.

Step 3

Report Delivery

No specific precautions. The sample is transported to the laboratory at ambient temperature.

Timeline: 3 to 4 weeks

Patient Instructions

1
Before the Test:No special preparation. Genetic counseling is advised to understand the implications of testing.
2
During the Test:A blood sample is drawn. The procedure is quick and minimally invasive.
3
After the Test:You can resume normal activities immediately. Results are typically available in 3-4 weeks.

About This Test

Who Should Get This Test

The purpose of this test is to identify disease-causing mutations in the TRIM37 gene to confirm a diagnosis of Mulibrey nanism in individuals presenting with characteristic clinical features. It also aids in carrier detection for at-risk family members and provides essential information for genetic counseling and reproductive planning.

How to Prepare

  • Ensure patient identity verification
  • Use EDTA vacutainer for blood collection
  • For FTA card, apply blood drop and air dry for 30 minutes
  • Label sample with patient details and date
  • Transport at room temperature

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Mulibrey nanism is a rare autosomal recessive disorder. Early genetic confirmation is crucial for managing growth, cardiac, and hepatic complications. This NGS test provides a definitive diagnosis, enabling timely intervention and family counseling."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or 1 drop on FTA card
ContainerEDTA vacutainer or FTA card
Collection MethodVenipuncture or Fingerstick

Sample Stability

Blood: 7 days at 2-8°C
Extracted DNA: 1 year at -20°C
FTA card: 6 months at room temperature
Sample Rejection Criteria:
  • Hemolyzed blood sample
  • Clotted blood sample
  • Insufficient sample volume
  • Improperly labeled sample
  • Sample received after prolonged transit time (>7 days)

Understanding Your Results

The interpretation of the TRIM37 gene NGS test is based on the detection of pathogenic or likely pathogenic variants in the TRIM37 gene, which confirms the diagnosis of Mulibrey nanism. Variants of uncertain significance (VUS) require further investigation and family segregation studies.
📊

Positive (Pathogenic variant detected)

Confirms diagnosis of Mulibrey nanism. Genetic counseling and family screening recommended.

📊

Negative (No pathogenic variant detected)

Does not rule out Mulibrey nanism if clinical suspicion is high. Consider other genetic causes or large deletion analysis.

📊

Variant of Uncertain Significance (VUS)

Cannot be classified as pathogenic or benign. Further testing of family members may help clarify.

⚠️ When to Consult a Doctor:

Consult a clinical geneticist or pediatrician if the child shows growth retardation, characteristic facial features, or unexplained liver/cardiac issues. Genetic testing is recommended for early diagnosis and management.

Limitations

  • This test does not detect large genomic rearrangements (deletions/duplications) unless specifically requested
  • Variants in non-coding regulatory regions may not be covered
  • Results should be interpreted in the context of clinical findings
  • Genetic counseling is recommended for result interpretation

Risks & Considerations

  • Minimal risk of bruising or infection at the blood draw site
  • Psychological impact of genetic results
  • Potential for uncertain results (VUS)

Interfering Factors

  • Contamination of sample with foreign DNA
  • Insufficient DNA quantity or quality
  • Presence of large deletions/duplications not detected by standard NGS
  • Mosaic variants may be missed

Compare With Similar Tests

TestTRIM37 Gene Mulibrey nanism NGS Genetic TestWhole Exome SequencingSanger Sequencing
ComparisonTRIM37 Gene Mulibrey nanism NGS Genetic TestWES covers all coding regions of genes, including TRIM37, but is more expensive and time-consuming. Targeted NGS is cost-effective for specific gene analysis.Sanger sequencing is used for targeted variant confirmation but is less efficient for full gene analysis compared to NGS.

Frequently Asked Questions

What is Mulibrey nanism?
Mulibrey nanism is a rare genetic disorder characterized by severe growth retardation, distinctive facial features, and multiple organ involvement including the liver, heart, and eyes. It is caused by mutations in the TRIM37 gene.
How is the TRIM37 gene test performed?
The test uses next-generation sequencing (NGS) technology to analyze the TRIM37 gene for mutations. A blood or saliva sample is collected, and DNA is extracted and sequenced.
What is the cost of the TRIM37 gene test in India?
The cost is Rs 20,000, which includes the genetic test, genetic counseling, and home sample collection in many cities.
Is fasting required before the test?
No, fasting is not required for this genetic test.
How long does it take to get the results?
Results are typically available within 3 to 4 weeks after the sample reaches the laboratory.
What sample is needed for the test?
The sample can be blood (2-3 ml in EDTA tube), extracted DNA, or a drop of blood on an FTA card.
Can the test be done at home?
Yes, DNA Labs India offers free home sample collection for online bookings in many cities across India.
What does a positive test result mean?
A positive result indicates the presence of a pathogenic mutation in the TRIM37 gene, confirming the diagnosis of Mulibrey nanism.
What if the test result is negative?
A negative result means no pathogenic mutation was found in the TRIM37 gene. However, if clinical suspicion remains, further genetic testing may be recommended.
Is genetic counseling included?
Yes, a genetic counseling session is included to draw a pedigree chart and discuss the implications of the test.
Will my insurance cover the cost?
Insurance coverage varies. It is recommended to check with your insurance provider. DNA Labs India offers the test at a discounted price of Rs 20,000.
Are raw data files provided?
Yes, DNA Labs India is transparent and provides raw data, FASTQ, and VCF files along with the clinical report.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.